Denali Therapeutics Ownership | Who Owns Denali Therapeutics?
Denali Therapeutics Ownership Summary
Denali Therapeutics is owned by 18.67% institutional investors, 9.80% insiders, and 71.53% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Scottish Mortgage Ord is the top mutual fund, with 4.48% of its assets in Denali Therapeutics shares.
DNLI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Denali Therapeutics | 18.67% | 9.80% | 71.53% |
| Sector | Healthcare Stocks | 42.52% | 10.82% | 46.66% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 13.17M | 8.82% | $305.91M |
| Blackrock funding, inc. /de | 12.29M | 7.17% | $178.45M |
| Vanguard group | 11.99M | 7.00% | $174.14M |
| Baillie gifford | 11.59M | 6.76% | $168.31B |
| Fmr | 6.34M | 3.70% | $92.06M |
| T. rowe price investment management | 5.64M | 3.29% | $81.87M |
| Ubs asset management americas | 5.47M | 3.19% | $79.35M |
| State street | 5.46M | 3.19% | $79.34M |
| Temasek (private) | 5.36M | 3.12% | $77.77M |
| Capital research global investors | 4.76M | 2.78% | $69.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Crestline management, lp | 3.41M | 85.26% | $49.52M |
| Foresite capital management vi | 1.00M | 5.61% | $14.52M |
| Stempoint capital lp | 1.73M | 5.05% | $25.19M |
| Boxer capital management | 250.00K | 1.16% | $3.63M |
| Palo alto investors lp | 408.01K | 1.10% | $5.92M |
| Casdin capital | 890.00K | 1.08% | $12.92M |
| Yiheng capital management | 469.98K | 1.01% | $6.82M |
| Lynx1 capital management lp | 261.69K | 0.77% | $3.80M |
| Pier capital | 301.17K | 0.68% | $4.37M |
| Dafna capital management | 168.50K | 0.60% | $2.45M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Holocene advisors, lp | 3.14M | 0.10% | 2.73M |
| T. rowe price investment management | 5.64M | 0.05% | 2.39M |
| Norges bank | 1.07M | 0.00% | 1.07M |
| Ubs group | 2.01M | 0.00% | 1.06M |
| Stempoint capital lp | 1.73M | 5.05% | 1.03M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 59.23K | 0.00% | -5.61M |
| Price t rowe associates inc /md/ | 4.57M | 0.01% | -2.01M |
| Flagship pioneering | - | - | -1.36M |
| Fmr | 6.34M | 0.00% | -1.20M |
| Gilder gagnon howe | - | - | -1.17M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.07M | 0.00% | 1.07M | $21.72M |
| Foresite capital management vi | 1.00M | 5.61% | 1.00M | $14.52M |
| Axa investment managers | 294.73K | 0.01% | 294.73K | $4.28M |
| Lynx1 capital management lp | 261.69K | 0.77% | 261.69K | $3.80M |
| Schonfeld strategic advisors | 226.20K | 0.02% | 226.20K | $3.28M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Dinuzzo private wealth | -2.00 |
| Toronto dominion bank | -2.00 |
| Global financial private client | -5.00 |
| Wealthtrak capital management | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 84 | -62.83% | 32,008,693 | -75.36% | 18 | 0.33% | 39 | -67.77% | 28 | -56.25% |
| Jun 30, 2025 | 230 | 4.07% | 137,233,427 | 3.48% | 80 | 1.33% | 122 | 14.02% | 66 | -17.50% |
| Mar 31, 2025 | 220 | -3.51% | 132,840,276 | 3.83% | 77 | 1.36% | 108 | -14.96% | 80 | 35.59% |
| Dec 31, 2024 | 227 | 2.71% | 127,936,943 | 1.24% | 75 | 1.36% | 125 | 8.70% | 60 | 3.45% |
| Sep 30, 2024 | 220 | 6.80% | 126,341,996 | 5.65% | 74 | 1.49% | 116 | 1.75% | 57 | -5.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Scottish Mortgage Ord | 6.53M | 4.48% | - |
| Vanguard Health Care Inv | 4.40M | 3.03% | -5.17M |
| Vanguard Total Stock Mkt Idx Inv | 3.73M | 2.56% | -77.42K |
| Vanguard US Total Market Shares ETF | 3.33M | 2.29% | -161.11K |
| American Funds SMALLCAP World A | 3.21M | 2.21% | -16.49K |
| Baillie Gifford US Equity Growth | 3.17M | 2.20% | -205.95K |
| iShares Russell 2000 ETF | 3.18M | 2.17% | - |
| Vanguard US Growth Investor | 3.03M | 2.08% | - |
| Vanguard Small Cap Index | 2.82M | 1.93% | -19.10K |
| T. Rowe Price Health Sciences | 2.22M | 1.52% | -278.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 12, 2025 | Schuth Alexander O. | COFO and Secretary | Sell | $39.88K |
| Aug 12, 2025 | Ho Carole | Chief Medical Officer | Sell | $39.88K |
| Aug 13, 2025 | Ho Carole | Chief Medical Officer | Sell | $11.80K |
| Jul 09, 2025 | Watts Ryan J. | President and CEO | Sell | $7.43M |
| Jan 06, 2025 | Ho Carole | Chief Medical Officer | Sell | $247.80K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | 9 |
DNLI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools